India's $5 billion medical device market has provided rich fishing grounds for US-based companies like Abbott Laboratories and Boston Scientific Corp, but the prospect of price caps being extended to more products sent shivers through their ranks. National Pharmaceutical Pricing Authority is also pushing to bring three more devices used while treating heart ailments under the ambit of price controls.
from Times of India https://ift.tt/2vXfHBg
via IFTTT
No comments:
Post a Comment